Safety Monitoring of Bivalent COVID-19 Vaccine Booster Doses Among Children Aged 5–11
After the CDC’s October 2022 recommendation for bivalent COVID-19 booster vaccination for children aged 5–11 years, children in this age group received approximately 953,359 bivalent booster doses from October 12, 2022, to January 1, 2023.
Early safety findings from v-safe and the Vaccine Adverse Event Reporting System (VAERS) for bivalent booster vaccination in children aged 5–11 years are similar to those described for monovalent booster vaccination. Neither myocarditis nor death were reported after bivalent booster vaccination.
COMPLETE DETAILS